Webinar | August 28, 2012

An Update on Dense Breast Tissue Management

Rachel F. Brem, MDPrincipal Investigator,ABUS Multicenter Prospective Clinical Trial

 

Imaging Technology News Webinar Series
-- Supported by an educational grant from U-Systems
 

Release date: September 27, 2012
 

CLICK HERE TO VIEW ARCHIVE
 
Statement of Purpose:
Automated Breast Ultrasound (ABUS) uses innovative, ground-breaking technology to efficiently supplement mammography and detect additional node negative, sub-centimeter invasive breast cancers. This webinar will provide an overview on the issues involving the management of dense breast tissue and potential strategies for incorporating ABUS into routine practice.
 
 
 
 
 
 
Learning Objectives:
Upon completion of this activity, participants will be able to:
  • Recognize the challenges associated with screening dense breast tissue
  • Demonstrate a working knowledge of the current literature on breast screening ultrasonography
  • Identify potential limitations and benefits of traditional hand-held breast ultrasound
  • Explain the value of automated breast ultrasound (ABUS)
  • Implement an ABUS screening program that focuses on building breast density awareness, quality assurance and workflow efficiency
 
Intended Audience:
This course is intended for radiologists and other health care providers involved in the screening, diagnosis and management of patients with breast cancer, as well as technologists involved in the acquisition of images for breast imaging.
 
Accreditation and Credit Designation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Academy for Continued Healthcare Learning (ACHL) and Scranton Gillette Communications. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
 
Presenters:
 
Rachel F. Brem, MD
Professor and Vice Chair, Department of Radiology
Director, Breast Imaging and Interventional Center
The George Washington University
Washington, DC
Principal Investigator,
ABUS Multicenter Prospective Clinical Trial
 
 
Judy C. Dean, MD
Fellowship training in ultrasound at Stanford
Private Practice Breast Center for over 20 years
Co-authored trial of Automated Breast US and subsequent Reader Study
Santa Barbara, CA
 
Copyright © 2012 ACHL
 
Disclosure Information:
 Dr. Brem:

Type of financial relationships: Consultant and Research Support: U-Systems 

Discussion of Off-label, Investigational or Experimental Drug Use: None

Dr. Dean:

Type of financial relationships:  None

Discussion of Off-label, Investigational or Experimental Drug Use: None

 
The Academy for Continued Healthcare Learning and Scranton Gillette Communications staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
 
CLICK HERE TO VIEW ARCHIVE

Related Content

iCAD, PowerLook Tomo Detection, computer-aided detection software, CAD, digital breast tomosynthesis, DBT, RSNA 2017
Technology | Computer-Aided Detection Software | March 27, 2017
March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S.
GE Healthcare, Senographe Pristina mammography system, launch, RSNA 2017, patient comfort
News | Mammography | March 24, 2017
GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening...
Solis Mammography, minimize recall rates, false positives, breast cancer, women's health
News | Mammography | March 16, 2017
Solis Mammography recently released a statement taking issue with incorrectly interpreted terminology used by reporters...
Parascript, AccuDetect CAD for Mammography, computer-aided detection, NCoBC 2017
News | Computer-Aided Detection Software | March 15, 2017
Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las...
Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
Solis Mammography, Texas, HB 1036, insurance coverage, 3-D mammography, tomosynthesis
News | Mammography | March 09, 2017
Solis Mammography, an independent provider of breast imaging services, believes that an educated patient makes the best...
Volpara Solutions, Volpara Enterprise 2.0 software, breast imaging, screening, ECR 2017
News | Breast Imaging | March 02, 2017
Volpara Solutions announced the European launch of Volpara Enterprise 2.0 software, which helps breast imaging...
digital breast tomosynthesis, DBT, synthesized 2-D mammography, S2D, screening recall rates, Radiology journal study
News | Mammography | February 22, 2017
A new digital breast tomosynthesis technique has the potential to reduce the rate at which women are called back for...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
Overlay Init